RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mayer Davidson to Humans

Back to Details
This is a "connection" page, showing publications Mayer Davidson has written about Humans.
Mayer Davidson
Connection Strength
2.033
Humans
  1. Davidson MB, Davidson SJ. Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians. Diabetes Obes Metab. 2024 Aug; 26(8):3475-3477.
    View in: PubMed
    Score: 0.045
  2. Davidson MB. In adults with BMI =27 kg/m2 and type 2 diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk. Ann Intern Med. 2023 11; 176(11):JC129.
    View in: PubMed
    Score: 0.044
  3. Davidson MB. Review of Prediabetes. JAMA. 2023 08 08; 330(6):564.
    View in: PubMed
    Score: 0.043
  4. Davidson MB. The Role of Prediabetes in the Metabolic Syndrome: Guilt by Association. Metab Syndr Relat Disord. 2023 05; 21(4):197-204.
    View in: PubMed
    Score: 0.042
  5. Davidson MB. A simplified straightforward protocol for the use of U-500 regular insulin. Diabetes Obes Metab. 2023 02; 25(2):634-636.
    View in: PubMed
    Score: 0.041
  6. Davidson MB. In adults with obesity without diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk. Ann Intern Med. 2022 10; 175(10):JC116.
    View in: PubMed
    Score: 0.040
  7. Davidson MB. Comment on Aleppo et al. The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737. Diabetes Care. 2022 04 01; 45(4):e84.
    View in: PubMed
    Score: 0.039
  8. Davidson MB. Historical review of the diagnosis of prediabetes/intermediate hyperglycemia: Case for the international criteria. Diabetes Res Clin Pract. 2022 Mar; 185:109219.
    View in: PubMed
    Score: 0.039
  9. Davidson MB. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916-2922. Diabetes Care. 2021 05; 44(5):e105.
    View in: PubMed
    Score: 0.037
  10. Davidson MB. Metformin Should Not Be Used to Treat Prediabetes. Diabetes Care. 2020 09; 43(9):1983-1987.
    View in: PubMed
    Score: 0.035
  11. Davidson MB. The "Cost-Effective" beneficial effect of pioglitazone on cardiovascular disease. Diabetes Res Clin Pract. 2020 07; 165:108223.
    View in: PubMed
    Score: 0.034
  12. Davidson MB. Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costs. Diabetes Obes Metab. 2020 05; 22(5):719-721.
    View in: PubMed
    Score: 0.034
  13. Davidson MB. SGLT-2 inhibitors were not linked to severe or nonsevere UTIs vs DPP-4 inhibitors or GLP-1 agonists. Ann Intern Med. 2019 12 17; 171(12):JC70.
    View in: PubMed
    Score: 0.033
  14. Hsia SH, Duran P, Lee ML, Davidson MB. Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study. J Diabetes. 2020 Jan; 12(1):91-94.
    View in: PubMed
    Score: 0.033
  15. Davidson MB. The Case for Using Human Insulin. Am J Med. 2020 02; 133(2):e23-e24.
    View in: PubMed
    Score: 0.032
  16. Davidson MB. Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes. Ann Intern Med. 2019 04 16; 170(8):JC39.
    View in: PubMed
    Score: 0.032
  17. Davidson MB. Delayed response to an injection of U-500 regular insulin is not rare. J Diabetes. 2019 Jul; 11(7):519-521.
    View in: PubMed
    Score: 0.032
  18. Davidson MB, Pan D. An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis. Diabetes Res Clin Pract. 2018 Jan; 135:102-110.
    View in: PubMed
    Score: 0.029
  19. Zgibor JC, Maloney MA, Malmi M, Fabio A, Kuo S, Solano FX, Tilves D, Tu L, Davidson MB. Effectiveness of certified diabetes educators following pre-approved protocols to redesign diabetes care delivery in primary care: Results of the REMEDIES 4D trial. Contemp Clin Trials. 2018 01; 64:201-209.
    View in: PubMed
    Score: 0.029
  20. Davidson MB. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections. JAMA. 2017 01 24; 317(4):363-364.
    View in: PubMed
    Score: 0.027
  21. Davidson MB. Diabetic retinopathy is not present in non-diabetic older overweight/obese African Americans. Diabetes Res Clin Pract. 2017 04; 126:322.
    View in: PubMed
    Score: 0.027
  22. Davidson MB. Diabetic retinopathy is not present in newly diagnosed diabetic patients. Diabetologia. 2016 12; 59(12):2727.
    View in: PubMed
    Score: 0.027
  23. Davidson MB, Kahn RA. A Reappraisal of Prediabetes. J Clin Endocrinol Metab. 2016 07; 101(7):2628-35.
    View in: PubMed
    Score: 0.026
  24. Davidson MB. Pioglitazone (Actos) and bladder cancer: Legal system triumphs over the evidence. J Diabetes Complications. 2016 08; 30(6):981-5.
    View in: PubMed
    Score: 0.026
  25. Kahn R, Davidson MB. Response to comment on Kahn and Davidson. The reality of type 2 diabetes prevention. Diabetes Care 2014;37:943-949. Diabetes Care. 2014 Dec; 37(12):e276-7.
    View in: PubMed
    Score: 0.023
  26. Davidson MB. Response to comment on Grunberger "insulin analogs-are they worth it? Yes!" Diabetes Care 2014;37:1767-1770 and Davidson "insulin analogs-is there a compelling case to use them? No!" Diabetes Care 2014;37:1771-1774. Diabetes Care. 2014 Oct; 37(10):e231.
    View in: PubMed
    Score: 0.023
  27. Kahn R, Davidson MB. Response to comment on Kahn and Davidson. The reality of type 2 diabetes prevention. Diabetes care 2014;37:943-949. Diabetes Care. 2014 Aug; 37(8):e187.
    View in: PubMed
    Score: 0.023
  28. Zgibor JC, Kuo S, Emerson S, Gittinger P, Solano FX, Tilves D, Maloney M, Davidson MB. Rationale, design, and implementation of a cluster randomized trial using certified diabetes educators to intensify treatment for glycemia, blood pressure and lipid control: REMEDIES 4D. Contemp Clin Trials. 2014 Sep; 39(1):124-31.
    View in: PubMed
    Score: 0.023
  29. Davidson MB. Insulin analogs--is there a compelling case to use them? No! Diabetes Care. 2014 Jun; 37(6):1771-4.
    View in: PubMed
    Score: 0.023
  30. Davidson MB, Pan D. Epidemiological ramifications of diagnosing diabetes with HbA1c levels. J Diabetes Complications. 2014 Jul-Aug; 28(4):464-9.
    View in: PubMed
    Score: 0.022
  31. Kahn R, Davidson MB. The reality of type 2 diabetes prevention. Diabetes Care. 2014 Apr; 37(4):943-9.
    View in: PubMed
    Score: 0.022
  32. Davidson MB. Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement. Diabetes Care. 2014; 37(1):3-4.
    View in: PubMed
    Score: 0.022
  33. Davidson MB, Duran P, Lee ML. Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos. Ethn Dis. 2014; 24(2):195-9.
    View in: PubMed
    Score: 0.022
  34. Davidson MB. Response to comment on: Davidson et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013;36:260-266. Diabetes Care. 2013 May; 36(5):e72.
    View in: PubMed
    Score: 0.021
  35. Davidson MB. Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610. Diabetes Care. 2013 Jan; 36(1):e10.
    View in: PubMed
    Score: 0.021
  36. Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care. 2013 Feb; 36(2):260-6.
    View in: PubMed
    Score: 0.020
  37. Davidson MB. Comment on: Hellemons et al. Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial. Diabetes Care 2011;34:2078-2083. Diabetes Care. 2011 Dec; 34(12):e188.
    View in: PubMed
    Score: 0.019
  38. Hsia SH, Navar MD, Duran P, Shaheen M, Davidson MB. Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus. Endocr Pract. 2011 Sep-Oct; 17(5):691-8.
    View in: PubMed
    Score: 0.019
  39. Davidson MB, Raskin P, Tanenberg RJ, Vlajnic A, Hollander P. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract. 2011 May-Jun; 17(3):395-403.
    View in: PubMed
    Score: 0.018
  40. Davidson MB, Echeverry D. Collaborative care for depression and chronic illnesses. N Engl J Med. 2011 03 31; 364(13):1278; author reply 1278-9.
    View in: PubMed
    Score: 0.018
  41. Davidson MB. Diagnosing diabetes with glucose criteria: worshiping a false God. Diabetes Care. 2011 Feb; 34(2):524-6.
    View in: PubMed
    Score: 0.018
  42. Davidson MB. Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck. Rev Recent Clin Trials. 2010 Sep; 5(3):138-42.
    View in: PubMed
    Score: 0.017
  43. Davidson MB, Blanco-Castellanos M, Duran P. Integrating nurse-directed diabetes management into a primary care setting. Am J Manag Care. 2010 Sep; 16(9):652-6.
    View in: PubMed
    Score: 0.017
  44. Davidson MB. Counterpoint: postprandial glucose levels are not a clinically important treatment target. Diabetes Care. 2010 Aug; 33(8):1908-10.
    View in: PubMed
    Score: 0.017
  45. Davidson MB. Correction to the 2010 report on the diagnosis and classification of diabetes. Diabetes Care. 2010 Apr; 33(4):e57.
    View in: PubMed
    Score: 0.017
  46. Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010 Mar; 87(3):415-21.
    View in: PubMed
    Score: 0.017
  47. Davidson MB, Navar MD, Echeverry D, Duran P. U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010 Feb; 33(2):281-3.
    View in: PubMed
    Score: 0.017
  48. Echeverry D, Duran P, Bonds C, Lee M, Davidson MB. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009 Dec; 32(12):2156-60.
    View in: PubMed
    Score: 0.016
  49. Davidson MB. Novel noninvasive breath test method for screening individuals at risk for diabetes: response to Dillon et al. Diabetes Care. 2009 Jul; 32(7):e88; author reply e89.
    View in: PubMed
    Score: 0.016
  50. Davidson MB. Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation. Curr Opin Endocrinol Diabetes Obes. 2009 Apr; 16(2):107-12.
    View in: PubMed
    Score: 0.016
  51. Davidson MB. How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions. Diabetes Care. 2009 Feb; 32(2):370-2.
    View in: PubMed
    Score: 0.016
  52. Davidson MB. Detailed treatment algorithms for effective nurse- and pharmacist-directed diabetes care: a personal approach. Diabetes Educ. 2009 Jan-Feb; 35(1):61-71.
    View in: PubMed
    Score: 0.016
  53. Davidson MB. No need for the needle (at first). Diabetes Care. 2008 Oct; 31(10):2070-1.
    View in: PubMed
    Score: 0.015
  54. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008 Jul; 93(7):2447-53.
    View in: PubMed
    Score: 0.015
  55. Davidson MB, Ramos L. Metformin does not suppress thyrotropin. Endocr Pract. 2008 Mar; 14(2):252-3.
    View in: PubMed
    Score: 0.015
  56. Davidson MB. The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: a narrative review. Curr Diabetes Rev. 2007 Nov; 3(4):280-6.
    View in: PubMed
    Score: 0.014
  57. Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract. 2007 Jul-Aug; 13(4):427-8.
    View in: PubMed
    Score: 0.014
  58. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care. 2007 Sep; 30(9):2233-5.
    View in: PubMed
    Score: 0.014
  59. Davidson MB. The dilemma of self-monitoring of blood glucose. Diabetologia. 2007 Mar; 50(3):497-9.
    View in: PubMed
    Score: 0.014
  60. Davidson MB, Ansari A, Karlan VJ. Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population. Diabetes Care. 2007 Feb; 30(2):224-7.
    View in: PubMed
    Score: 0.014
  61. Davidson MB. Clinical implications of the DREAM Study. Diabetes Care. 2007 Feb; 30(2):418-20.
    View in: PubMed
    Score: 0.014
  62. Ballani P, Tran MT, Navar MD, Davidson MB. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
    View in: PubMed
    Score: 0.013
  63. Davidson MB. Does the metabolic syndrome exist: response to Grundy. Diabetes Care. 2006 Nov; 29(11):2565; author reply 2565-6.
    View in: PubMed
    Score: 0.013
  64. Tran MT, Navar MD, Davidson MB. Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes. Diabetes Care. 2006 Jun; 29(6):1395-6.
    View in: PubMed
    Score: 0.013
  65. Davidson MB, Castellanos M, Duran P, Karlan V. Effective diabetes care by a registered nurse following treatment algorithms in a minority population. Am J Manag Care. 2006 Apr; 12(4):226-32.
    View in: PubMed
    Score: 0.013
  66. Davidson MB. Recommendations for management of diabetes during Ramadan. Diabetes Care. 2006 Mar; 29(3):745; author reply 746.
    View in: PubMed
    Score: 0.013
  67. Echeverry D, Dike M, Jovanovic L, Wollitzer AO, Westphal S, Mudaliar S, Washington C, Davidson MB. Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac event. Am J Manag Care. 2005 Dec; 11(12):758-64.
    View in: PubMed
    Score: 0.013
  68. Davidson MB. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al. Diabetes Care. 2005 Oct; 28(10):2597; author reply 2597-8.
    View in: PubMed
    Score: 0.012
  69. Davidson MB. The effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care. Am J Manag Care. 2005 Sep; 11(9):585; author reply 585.
    View in: PubMed
    Score: 0.012
  70. Davidson MB, Bate G, Kirkpatrick P. Exenatide. Nat Rev Drug Discov. 2005 Sep; 4(9):713-4.
    View in: PubMed
    Score: 0.012
  71. Davidson MB. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005 Jun; 28(6):1531-3.
    View in: PubMed
    Score: 0.012
  72. Davidson MB. SF-36 and diabetes outcome measures. Diabetes Care. 2005 Jun; 28(6):1536-7.
    View in: PubMed
    Score: 0.012
  73. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005 Apr; 118(4):422-5.
    View in: PubMed
    Score: 0.012
  74. Davidson MB. Starting insulin therapy in type 2 diabetic patients: does it really matter how? Diabetes Care. 2005 Feb; 28(2):494-5.
    View in: PubMed
    Score: 0.012
  75. Davidson MB. Glycemia and risk for cardiovascular disease. Ann Intern Med. 2005 Feb 01; 142(3):227; author reply 227-8.
    View in: PubMed
    Score: 0.012
  76. Davidson MB. Thiazolidinediones. N Engl J Med. 2005 Jan 13; 352(2):205-7; author reply 205-7.
    View in: PubMed
    Score: 0.012
  77. Davidson MB. Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005 Jan; 28(1):222-4.
    View in: PubMed
    Score: 0.012
  78. Davidson MB, Dulan S, Duran P, Bazargan M. Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients. Diabetes Care. 2004 Sep; 27(9):2260-1.
    View in: PubMed
    Score: 0.012
  79. Hsia SH, Bazargan M, Davidson MB. Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
    View in: PubMed
    Score: 0.012
  80. Roy R, Navar M, Palomeno G, Davidson MB. Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population. Diabetes Care. 2004 Jul; 27(7):1741-2.
    View in: PubMed
    Score: 0.011
  81. Davidson MB. Triple therapy: definitions, application, and treating to target. Diabetes Care. 2004 Jul; 27(7):1834-5.
    View in: PubMed
    Score: 0.011
  82. Davidson MB. Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et al. Diabetes Care. 2004 Jul; 27(7):1846; author reply 1847-8.
    View in: PubMed
    Score: 0.011
  83. Davidson MB. Type-1 diabetes mellitus with insufficient serum immunoreactive insulin elevation after subcutaneous NPH-insulin injection. Diabetes Res Clin Pract. 2004 Jun; 64(3):229.
    View in: PubMed
    Score: 0.011
  84. Davidson MB. Status of research funding by the American Diabetes Association--5th and final year. Diabetes. 2004 May; 53(5):1403.
    View in: PubMed
    Score: 0.011
  85. Davidson MB. Status of research funding by the American Diabetes Association--5th and final year. Diabetes Care. 2004 May; 27(5):1235.
    View in: PubMed
    Score: 0.011
  86. Davidson MB, Bazargan M, Bakris G, Peters Harmel A, Campese V, Basta E. ImmunoDip: an improved screening method for microalbuminuria. Am J Nephrol. 2004 May-Jun; 24(3):284-8.
    View in: PubMed
    Score: 0.011
  87. Davidson MB. More evidence to support "outsourcing" of diabetes care. Diabetes Care. 2004 Apr; 27(4):995.
    View in: PubMed
    Score: 0.011
  88. Davidson MB. Novel risk factors for atherosclerosis. JAMA. 2004 Jan 21; 291(3):301; author reply 301-2.
    View in: PubMed
    Score: 0.011
  89. Davidson MB, Landsman PB, Alexander CM. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care. 2003 Dec; 26(12):3329-30.
    View in: PubMed
    Score: 0.011
  90. Davidson MB. Metabolic syndrome/insulin resistance syndrome/pre-diabetes: new section in diabetes care. Diabetes Care. 2003 Nov; 26(11):3179.
    View in: PubMed
    Score: 0.011
  91. Davidson MB. Is treatment of insulin resistance beneficial independent of glycemia? Diabetes Care. 2003 Nov; 26(11):3184-6.
    View in: PubMed
    Score: 0.011
  92. Echeverry DM, Dike MR, Washington C, Davidson MB. The impact of using a low-literacy patient education tool on process measures of diabetes care in a minority population. J Natl Med Assoc. 2003 Nov; 95(11):1074-81.
    View in: PubMed
    Score: 0.011
  93. Davidson MB. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003 Aug; 26(8):2281-7.
    View in: PubMed
    Score: 0.011
  94. Davidson MB. Status of research funded by the American Diabetes Association--year 4. Diabetes. 2003 Jun; 52(6):1588.
    View in: PubMed
    Score: 0.011
  95. Davidson MB. Status of research funded by the American Diabetes Association--year 4. Diabetes Care. 2003 Jun; 26(6):1940.
    View in: PubMed
    Score: 0.011
  96. Davidson MB. The case for "outsourcing" diabetes care. Diabetes Care. 2003 May; 26(5):1608-12.
    View in: PubMed
    Score: 0.011
  97. Davidson MB. Tests of glycemia. Ann Intern Med. 2003 Mar 18; 138(6):517; author reply 517.
    View in: PubMed
    Score: 0.010
  98. Davidson MB. Editor's comment: "It ain't necessarily so". Diabetes Care. 2002 Nov; 25(11):2116.
    View in: PubMed
    Score: 0.010
  99. Pradhan R, Fong D, March C, Jack R, Rezapour G, Norris K, Davidson MB. Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study. J Diabetes Complications. 2002 Nov-Dec; 16(6):377-81.
    View in: PubMed
    Score: 0.010
  100. Davidson MB. Counterpoint: the oral glucose tolerance test is superfluous. Diabetes Care. 2002 Oct; 25(10):1883-5.
    View in: PubMed
    Score: 0.010
  101. Davidson MB. Treatment decisions for type 2 diabetes. JAMA. 2002 Apr 03; 287(13):1646-7; author reply 1647-8.
    View in: PubMed
    Score: 0.010
  102. Davidson MB. Status of research funded by the American Diabetes Association: year 3. Diabetes Care. 2002 Mar; 25(3):626.
    View in: PubMed
    Score: 0.010
  103. Davidson MB. Have we got the new diagnostic criteria for diabetes and impaired glucose states right? No. Curr Diab Rep. 2002 Feb; 2(1):3-4.
    View in: PubMed
    Score: 0.010
  104. Davidson MB. Staying the course--with a few adjustments. Diabetes Care. 2002 Jan; 25(1):1.
    View in: PubMed
    Score: 0.010
  105. Hsia SH, Davidson MB. Established therapies for diabetes mellitus. Curr Med Res Opin. 2002; 18 Suppl 1:s13-21.
    View in: PubMed
    Score: 0.010
  106. Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, Hanley DA, Pittas AG, Tjosvold L, Johnson JA. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Oct; 99(10):3551-60.
    View in: PubMed
    Score: 0.006
  107. Shimizu T, Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. [Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes]. Nihon Rinsho. 2012 May; 70 Suppl 3:591-601.
    View in: PubMed
    Score: 0.005
  108. Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012 Feb 27; 344:e486.
    View in: PubMed
    Score: 0.005
  109. Toscos TR, Ponder SW, Anderson BJ, Davidson MB, Lee ML, Montemayor-Gonzalez E, Reyes P, Link E, McMahon KL. Integrating an Automated Diabetes Management System into the family management of children with type 1 diabetes: results from a 12-month randomized controlled technology trial. Diabetes Care. 2012 Mar; 35(3):498-502.
    View in: PubMed
    Score: 0.005
  110. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009 Jan; 32(1):193-203.
    View in: PubMed
    Score: 0.004
  111. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008 Jan; 31(1):173-5.
    View in: PubMed
    Score: 0.004
  112. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006 Aug; 29(8):1963-72.
    View in: PubMed
    Score: 0.003
  113. Sarkisian CA, Brusuelas RJ, Steers WN, Davidson MB, Brown AF, Norris KC, Anderson RM, Mangione CM. Using focus groups of older African Americans and Latinos with diabetes to modify a self-care empowerment intervention. Ethn Dis. 2005; 15(2):283-91.
    View in: PubMed
    Score: 0.003
  114. Sarkisian CA, Brusuelas RJ, Steers WN, Davidson MB, Brown AF, Norris KC, Anderson RM, Mangione CM. For the patient. Managing diabetes with cultural sensitivity and self-empowerment. Ethn Dis. 2005; 15(2):351.
    View in: PubMed
    Score: 0.003
  115. Brandle M, Davidson MB, Schriger DL, Lorber B, Herman WH. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003 Jun; 26(6):1796-801.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support